Bioactive polysaccharides from medicinal plants used in woundhealing and against inflammation Berit Smestad Paulsen Department of Pharmacognosy School of Pharmacy Oslo, Norway MALI http://www.xs4all.nl/~ilja/mali/mali-map-htm Malian population: Population: ca 12 mill. Area 47.2% : 0-14 years 5,5% : > 60 years Fertility rate: 6.7 children born/woman Child mortality: 12% Rate of alphabetization: 1 241 248 km2 Expected living age: 47 years Age repartition: Ethnic diversity: Sénoufo, Bambara, Sarakolé, Milinké, Peulh, Dogon, Bobo, Sonrhaï, Tamacheck…….. Men – 31% Women – 15% Appr. 75% in rural areas Photo: C.S. Nergård Curative urban based health service, limited curative or preventive health service in the rural areas 59% of the population have healthservice within 15 km Medical doctors 1:16,000 inhabitant (Norway: 1:272) Local clinics: Department of Traditional Medicine (DMT) difficult to keep the personnel Funding not available for long time treatment Traditional medicine is composed of: -Secret traditional medicine TRADITIONAL HEALERS -Methods of diagnosis 1:500 inhabitants -Methods of treatment 80% use traditional medicine Ethnopharmacology The observation, identification, description and experimental investigation of the ingredients and the effects of such indigeneous drugs is a truly interdisiplinary field of research which is very important in the study of traditional medicine The interdisiplinary scientific exploration of biologically active agents traditionally employed or observed by man. Traditional preparation and adminiatration Collection of the plant part Use either fresh or dry Preparation Dry powder Infusion or macerate Normally extract wash the body or drink the Preparation of the polysaccharides Ethanol extraction Water extraction 50oC Dialysis, freezedrying Anion exchange chromatography gelfiltration Water extraction 100oC Dialysis, freezedrying Anion exchange chromatography gelfiltration Structure elucidation Methanolysis, Carbohydrate composition Methylation TMS GC studies GC-MS Linkage determination NMR anomeric configuration, sequence Mw - gelfiltration Enzymatic degradation Gives polygalacturonans, hairy regions, oligosaccharide sidechains etc. Immunomodulation associated with activation of the complement system: Thymus dependant antibody response Regulation of specific cyclic antibody production Regulation of IgM-IgG switch Modulation of T and B cell proliferation Induction of supressor or helper T-cells Modulation of monokine or lympokine release Structures of pectic type polysaccharides Arabinogalactan 1,4,gal Arabinogalactan type I type II 1,3,6 gal Rhamnogalacturonan Hairy region, alternating rha / galA backbone Rhamnogalacturonan I II Macro-oligosaccharide, 20 units, complex Proposed structure of pectins, Perez et al 2003 Hairy region of rhamnogalacturonan I g2Rha1g4GalA1g2Rha1g4GalA1g2Rha1g4GalA1g2Rha1g4GalA1g 4 4 4 h h h 1 1 1 Araf Gal Gal 5 6 6 h h h 1 1 1 Araf1g3Araf Araf1g3Gal Gal 5 6 6 h h h 1 1 1 Araf Gal Araf1g3Gal 5 6 6 h h h 1 1 1 Araf1g3Araf Araf1g3Gal Gal 5 6 h h 1 1 Araf Araf Are polysaccharides transported over membranes? Peyer´s patches Yamada et al. produced antibodies against bupleuran Detected polymers with binding sites for the antibodies in liver Bupleuran epitopes Medicinal plants used for woundhealing in Mali Baccharoides adoensis var. kotschyana (Sch.Bip.ex.Walp.) M.A.Isawumi, G.ElGhazaly & B.Nordenstam (Vernonia kotschyana (Sch.Bip.ex.Walp.)) Cochlospermum tinctorium Perr. Glinus oppositifolius (L.) A. DC. Biophytum petersianum Klotzch Baccharoides adoensis var. kotschyana (Vernonia kotschyana) Powdered roots are recognised by the government in Mali as a natural drug for the treatment of gastroduodenal ulcers. GASTROCEDAL Characteristics of A.2 Acacia gum (std.) A,2,2 Vk100 A1 A2 A.2.1 Gelfiltration of A.2 from V.kotschyana. Effect on the Yariv reagent, separation after enzymic degradation of A.2.2 A2.1 A2.2 Effect of A.2.1 after enzymatic degradation Effect of A.2.2 after enzymic degradation Vk100A2a 10 g/mL 1 Vk100A2b 1,5 0,5 0,0 Vk100A2a 1 Vk100A2b B-cells 6,0 * 0,0 Vk100A2a 1 Vk100A2b BR2IIc 100 g/mL * ConA 5 g/mL * Anti-IgM F(ab)2 10 g/mL * 10 g/mL 1,0 1,5 8,0 100 g/mL 1,0 (B) 10 g/mL * Spleen-cells 100 g/mL Acid phosphatae Control * Stimulation index (SI) 2,0 BR2IIc 100 g/mL * 100 g/mL 3,0 2,5 10 g/mL 3,5 100 g/mL (A) 10 g/mL Alamar blue Control * OD 405 Spleen-cells BR2IIc 100 g/mL 4,0 ConA 5 g/mL 4,5 Anti-IgM F(ab)2 10 g/mL 5,0 100 g/mL 2,0 10 g/mL 2,5 100 g/mL 0,0 Control 0,5 Control Stimulation index (SI) Mitogenic activity of fractions from V. kotchyana Alamar blue * (C) * 7,0 5,0 * 4,0 3,0 * 2,0 1,0 Macrophages A Anti-CD14 B Donor 1 Donor 4 9000 8000 7000 8000 6000 5000 4000 3000 6000 2000 1000 0 2000 7000 5000 4000 3000 1000 0 Vk100A2a 7 Vk100A2b 11 LPS 12 250 ng/ml 10 25 ng/ml 9 2.5 ng/ml 8 500 g/ml 7 250 g/ml 100 g/ml 6 13 10 g/ml inulin Vk100A2a 5 10 g/ml 4 500 g/ml 250 g/ml 3 100 g/ml 10 g/ml 2 9 Vk100A2b 10 9 8 7 6 5 4 3 2 1 0 1 8 10 11 CXCL12 100 ng/ml 6 10 g/ml 5 100 g/ml 4 1 g/ml 3 Medium 2 100 g/ml 1 1 g/ml 11 10 g/ml 10 Medium 9 Vk100A2b Medium Nitrite (g/ml) C 8 CXCL12 100 ng/ml Vk100A2a 7 100 g/ml 6 1 g/ml 5 10 g/ml 4 Medium 3 100 g/ml 1 g/ml 2 10 g/ml 1 Medium # of migrated cells 9000 Stimulation of macrophages with Vk100A2 fractions, chemotaxis in response of diff. conc. in 2 diff. patients Yield (%, w/w), total carbohydrate content (%, w/w) and monosaccharide composition (mol.%) of the fractions Vk100A2a and Vk100A2b obtained after size exclusion chromatography on Sephacryl S-400 of Vk100A2. Polysaccharide fraction Yield (%, w/w) a Total carbohydrate (%, w/w) Monosaccharide composition (mol.%) Arabinose Rhamnose Galactose Xylose Mannose Glucose Fucose Glucuronic acid Galacturonic acid Reaction with Yariv-reagent Protein content (%, w/w) b a based on dried and pulverized root b based on the Lowry method Vk100A2 a b 0.05 0.34 86 68 31.3 11.0 24.4 0.7 0.3 5.7 trace 26.4 + < 0.5 3.9 4.9 4.9 trace trace 1.8 trace 84.6 < 0.3 Vo 1,6 A 1,4 Absorbance 1,2 Vk2a-HR 1 0,8 0,6 0,4 Vi 0,2 0 11 15 19 23 27 31 35 39 43 47 51 55 59 63 67 71 75 Vo 0,7 79 83 B 0,6 0,5 AF-HR Absorbance 0,4 0,3 0,2 Vi 0,1 0 11 15 19 23 27 31 35 39 43 47 51 55 59 63 67 71 75 79 83 -0,1 C AF-GN-3 0,16 AF-GN-1 0,14 Absorbance 0,12 AF-GN-5 AF-GN-4 AF-GN-6 AF-GN-7 AF-GN-2 0,1 AF-GN-8 0,08 0,06 0,04 0,02 0 11 15 19 23 27 31 35 39 43 47 51 Fraction no. 55 59 63 67 71 75 79 83 Degradation of VKA2 by a, polygalacturonase followed by b. arabinofuranosidase followed by c. galactanase Effect of the different fractions on the complement system 100,0 Vk2a % Inhibition of hemolysis 80,0 Vk2a-HR AF-HR 60,0 AF-GN-1 AF-GN-2 AF-GN-3 40,0 AF-GN-4 AF-GN-5 20,0 0,0 0 -20,0 5 10 15 20 25 Sample concentration (g/mL) 30 35 B cells 10,0 A 9,0 * Stimulation index (SI) 8,0 * Mitogenic activity on the original fraction and the degradation products * 7,0 6,0 * 5,0 * 4,0 * 3,0 * 2,0 AF-GN-2 AF-GN-1 AF-HRGN-mix 1 AF-HR Vk2a-HR Vk2a BR2IIc 0,0 Control 1,0 Sample concentration (100g/mL) Spleen cells B 2,5 * 2,0 * * * 1,0 * Sample concentration (100g/mL) AF-GN-2 AF-GN-1 AF-HRGN-mix 1 AF-HR Vk2a-HR Vk2a 0,0 BR2IIc 0,5 Control OD (405 nm) * 1,5 Conclusion Bioactive parts on the VK1002a polysaccharide are situated both in the inner and in the external part of the pectic arabinogalactan Cochlospermum tinctorium, root The root is traditionally used agains gastric ulcer, often together with the powder from the root of V. kotchyana Cochlospermum tinctorium activity on whole spleen cells Cochlospermum tinctorium activity on B - cells Glinus oppositifolius (L.) A. DC. (Aizoaceae) Used in traditional medicine for the treatment of joint pains, inflammations, fever, malaria, skin disorders and wounds. The immune system an important factor in the wound healing process. Plant polysaccharides reported to have immunomodulating activities. Glinus oppositifolius (L.) A. DC. (Aizoaceae) 50°C water extract separated into one neutral (GON) and two acidic fractions (GOA1 and GAO2). M on osa c ch aride GO Arabi n os e 9 Rh am n os e 7 ,2 F uc os e 1 ,3 Xy lose 1 ,1 M an no s e 1 ,7 Galac t os e 14 ,9 Galac tur on i c aci d 58 ,9 Gluco s e 5 4 -O-M e -Glucu ro n ic 1 ,1 ac id Mole cu la r we igh ts ( De ter m ine d us in g SEC/ MALLS ) GON 32 ,2 0 ,1 0 ,5 2 ,3 5 ,1 34 ,5 25 ,4 - GOA1 23 4 3 ,4 4 ,5 44 ,6 13 ,4 3 ,6 3 ,5 7 0kD a GOA2 4 ,4 9 ,1 1 ,1 0 ,4 0 ,6 9 ,2 71 ,5 3 ,2 0 ,5 39k Da The monosaccharide compositions of the crude water extract GO and the different fractions obtained after ion exchange chromatography. Complement fixating activity I The complement fixating activities determined in vitro. GOA1 shows an ICH50 value at 40 g/ml (the lowest concentration of sample needed to give 50% inhibition of lysis of antibody-sensitized SRBS). Plantago major L. was used as a positive control. % inhibition of hemolysis 100 90 80 70 60 50 40 30 20 10 0 GOA1 GOA2 GON PMII 0 50 100 150 200 250 300 350 400 450 500 Concentration ug/m l Complement activation associated with several immune reactions; activation of macrophages and lymphocytes, immunopotenation and regulation of cyclic antibody production, antiinflammatory effects. Linkage analysis Type of linkage T-Araf Ara 1,3 Ara 1,5 Ara 1,3,5 Ara 1,2,5 GOA1 Original Hydrolysed 5,4 0,03 1,6 0,06 3,9 0,05 1,1 0,03 0,2 0,03 T-Rha Rha 1,2 Rha 1,2,4 1 0,4 0,7 0,3 0,5 0,8 T-Xyl Xyl 1,4 Xyl 1,2,4 0,9 0,6 0,2 0,2 0,4 0,06 Man 1,2 2,3 1,5 T-Galf T-Galp Gal 1,4 Gal 1,3 Gal 1,6 Gal 1,3,4 Gal 1,4,6 Gal 1,3,6 Gal 1,3,4,6 0,2 2 2,8 3,6 4,2 0,3 0,1 8,6 1,6 0,09 1,5 1,8 1,9 4,8 0,1 0,05 2,8 0,05 T-Glc Glc 1,4 Glc 1,4,6 0,4 1,1 0,4 0,2 0,6 0,1 T-GalA GalA 1,4 1,3 5,7 2,0 4,7 T-4-O-Me-GlcA 1,3 4-O-Me-GlcA 1,4 0,5 1,2 0,3 The main linkages in GOA1: GalA 14 Rha 12, 12,4 Gal 1 4, 1 3,4 Gal 1 3, 1 6, 1 3,6, 1 3,4,6 Araf T, 1 3, 1 5, 1 3,5 The migration of different leukocyte populations in response to GOA1. # of migrated cells Chemotaxis of macrophages, B-cells, and T-cells. 5 4 3 2 1 0 Medium 100 ug SB1 10 ug SB1 1 ug SB1 Medium 100 ug SB2 10 ug SB2 1 ug SB2 SDF-1 Macrophages T-cells IP -1 0 l ng /m ug /m l 1 10 0 O A2 O A2 G l ug /m l G ug /m 10 G O A2 ed iu m 10 0 M G O A2 l ng /m ug /m l G O A1 1 10 0 ug /m l l 0 O A1 GOA2 GOA2 GOA2 1 GOA2 100 10 ug/ml ug/ml 100 ug/ml ng/ml G Medium ug /m GOA1 GOA1 GOA1 1 GOA1 100 10 ug/ml ug/ml 100 ug/ml ng/ml 10000 G Medium 20000 10 0 30000 O A1 5 40000 G 10 50000 ed iu m 15 60000 M 20 10 0 25 O A1 # of migrated cells # of migrated cells B-cells Conclusion Two different pectic polysaccharides isolated from Glinus oppositifolius (L.) A. DC. (Aizoaceae) with potent complement fixating activity. Further structure- and activity studies in progress. A complement fixing polysaccharide from Biophytum petersianum Klotzch, a medicinal plant from Mali, West Africa. Bp 100, Fr. III, and degradation fraction of Fr. III with the polygalacturonase, Fr.III 1 is the hairy region Monosaccharide Arabinose Rhamnose Fucose Xylose Mannose Galactose Galacturonic acid Fr.III 8,5 7,3 0,8 7,2 0,4 9,0 64,1 1 7,9 22,6 1,1 5,0 2,0 20,0 38,5 2 11,1 12,3 2,3 7.1 0,8 8,5 55,2 3 10,4 7,7 1,9 9,4 1,0 6,4 60,8 Effect of polysaccharide fractions from B.petersianum on the complement system 120 100 inhibition % 80 Bp100 Bp100 -I 60 Bp100-II Bp100-III PMII 40 20 0 0 100 200 300 400 500 600 Linkage analyses of the different monosaccharides present in the fraction Bp 100 Fr.III and the fractions after polygalacturonase treatment Type of link T-Ara 1->5 Ara T-Xyl 1->2 Xyl 1->4 Xyl T-Rha 1->2 Rha 1->3 Rha 1->3,4 Rha 1->2,4 Rha T-Fuc T-Gal 1->3 Gal 1->6 Gal 1->3,6 Gal T- GlcA T- GalA 1->4 GalA 1->3,4 GalA 1->2,4 GalA B.P Orig 6,2 2,7 l6,4 0 1,2 1,2 3,4 0,8 0,5 2,5 1 3,1 2,2 1,1 3,3 tr 2,5 52,3 8,5 1,1 B.P.I 7 1,1 4,9 0 0,6 2,4 14,2 0,8 0 6,3 1,3 6,8 4,9 3,1 6,2 tr. 2,3 30,2 6,8 1,1 B.P.II 8,5 0 6,1 1,3 3,1 5,2 2,5 2,9 1,8 0,7 2,4 5 3,4 0 0,6 B.P.III 8 0 9,7 0 2,8 2 3 1,6 1,6 0,5 2,1 1,9 3,7 0 1,4 4,1 31,2 17,9 3,3 6,4 30,1 22,2 3 Major features of the regions of BP BP Hairy region, alternating GalA and Rha, sidechains of 1/3 of Rha BP II MMW High GalA, 1/3 branched BP I HMW II LMW High GalA, 2/3 branched Conclusions Activity compared with structural differences indicate that the hairy region is important for the activity of the native polymer. It appears also that the regions of the original polymer containing sections of galacturonic acids that are highly branched, also are important for the activity when comparing those fractions with that of PMII not having long sections of branched uronic acid chains. Comparing the activity of Fr.III.1 with that of the native polymer, it is also obvious that the regions of the polymers giving rise to the other two fractions have an inhibitory effect on the activity of the total polymer. Bioactive polysaccharides from the stems of Acanthus ebracteatus Sanya Hokputsa, Stephen Harding, Kari Inngjerdingen, Kornelia Jumel, Terje Michaelsen, Thomas Heinze, Andreas Kochella and Berit Smestad Paulsen Traditional use in Thailand and other countries in the region Sea holly, a mangrove plant In Malaysia, In China seeds against cough and boils hepatitis, lymphoma and astma In Thailand Root and stem for skin diseases and longevity Crushed leaves on inflamed joints Decoction of the whole plant against inflammation Separation on DEAE-Sepharose, 50oExtract 3.5 2.0 concentration of N aC l A 602 1.5 2.5 2.0 1.0 1.5 A 601 1.0 0.5 0.5 0.0 0.0 0 50 100 150 200 F raction num ber 250 300 NaCl (M) Absorbance at 490 nm 3.0 Separation on DEAE-Sepharose, 100oExtract 3.5 2.0 concentration of N aC l A 1002 1.5 2.5 2.0 1.0 A 1001 1.5 1.0 0.5 0.5 0.0 0.0 0 50 100 150 200 Fraction num ber 250 300 NaCl (M) Absorbance at 490 nm 3.0 Table 1. Appearance, yield, protein content and sugar composition (mol%) of polysaccharide fractions obtained after separation of the crude extracts on the DEAESepharose Fastflow column 60C water extract 100C water extract A601 A602 A1001 A1002 cream, fluffy white, fluffy white, fluffy white, fluffy Yieldsa 20.0 50.2 10.1 48.9 Protein content (w/w) 4.8 6.4 5.9 6.2 Ara 9.1 11.0 13.3 6.1 Rha 0.9 12.3 0.8 7.5 Fuc trace 0.8 trace 0.3 Xyl 0.6 1.4 1.1 0.8 Man 3.6 1.4 2.3 0.4 Glc 4.3 3.1 9.9 2.2 Gal 55.0 18.7 39.6 11.0 3-O-Me-Gal 26.5 1.3 33.0 1.9 - 50.0 - 69.8 Appearance Sugar compositionb GalA a calculated as weight % of applied material b mol% of total carbohydrate content Effect of the fractions in the complement system Table 2. Glycosidic linkage composition (mol%) of the polysaccharide fractions obtained after separation of the crude extracts on the DEAE-Sepharose Fast-flow column Sugar Type of linkage Fraction A601 A602 A1001 A1002 Tf 1.8 2.5 2.7 2.3 1,3 1.0 - 0.7 - 1,5 4.9 7.2 6.0 3.8 1,3,5 1.4 1.3 2.1 - 1,2,5 - - 1.8 - T - 3.1 - - 1,2 - 7.3 0.8 7.5 1,2,4 - 1.9 - trace Fuc T - - trace 0.3 Xyl T - - 1.1 0.8 Man T 3.6 1.4 2.3 - Glc T trace trace 0.9 trace 1,4 4.3 3.1 7.9 - 1,6 - 0.4 - 1,4,6 - - 0.6 - Tp 7.8 3.5 8.5 1.7 Tf 4.1 - 1.5 - 1,4 55.8 9.8 57.9 5.3 1,6 4.6 1.4 2.3 - Ara Rha Gala aas 1,4,6 9.5 3.9 4.4 combined amount of galactose and 3-O-Me-galactose 1,2,4 1.4 5.3 0.5 Linkages present Neutral polymers Arabinose, f (minor) Acidic polymers Arabinose, f T; 1,3; 1,5M; 1,3,5 Galactose, p (major) T; 1,4M; 1,6; 1,4,6 Incl. 3-O-methyl-Galactose Rhamnose, p T; 1,5 T; 1,2M; 1,2,4 Galactose, p T; 1,4m; 1,4,6 Incl. 3-O-methyl-Galactose Galacturonic acid, p T; 1,4M CH3-O-C 1 H -N M R NMR of the Neutral Fraction Acetyl 6 5 4 3 2 1 ppm 13 108,5 – a C1 L-Araf C -N M R 104,5 – b1-4 gal 105,3 – b1-4 3-O-megal 58,5 – OCH3 21,2 and 174,8 – acetylgroups 180 160 140 120 100 ppm 80 60 40 20 1 H -N M R 13 6 5 4 3 2 C -N M R 1 ppm 180 160 140 120 100 80 60 ppm Summary of 13C chemical shifts for A1002 Chemical shift (ppm) Residues C-1 C-2+3 C-4 C-5 C-6 a-(14)-GalpA 100,2 69.2-69.7 79.2-79.7 71.5 175.8 6-Me-GalpA 101.0 69.2-69.7 79.2-79.7 71.5 171.7 b-(14)-Galp 104.4 72.5 n.d n.d 61.8 a-(15)-Araf 108.6 n.d n.d n.d - a-(12)-Rhap n.d n.d n.d n.d 17.6 40 20 Gelfiltration of the acidic fraction 1002 1.8 A 1002e Absorbance at 490 nm 1.6 1.4 A 1002d 1.2 A 1002c 1.0 A 1002b 0.8 0.6 A 1002f A 1002a 0.4 0.2 0.0 100 200 300 400 E lution volum e (m l) 500 600 Table 4. Yield, weight average molecular weight (Mw) and sugar composition (mol%) o f A1002 sub- fractions obtained after size exclusion chromatography of A1002 Fraction A1002a Yieldb A1002b A1002c A1002d A1002e A1002f PM IIa 8.6 8.6 24.0 16.0 31.4 3.4 150030 27620 586 423 324 294 Ara 7.3 7.1 5.6 4.3 3.9 4.3 8.8 Rha 5.9 5.7 5.6 5.5 5.5 5.7 4.2 Fuc 0.6 0.3 0.3 0.3 trace 0.3 - Xyl 0.7 0.6 0.6 0.6 0.5 0.6 - Man 1.4 - - - - - - Glc 5.1 2.1 1.5 1.6 1.5 2.3 7.3 Gal 16.2 13.1 10.0 8.2 6.9 8.1 8.0 3-O-Me-Gal 13.9 1.8 0.5 trace trace trace - Total neutral sugars 51.1 30.7 24.1 20.5 18.3 21.3 28.3 49.1 69.4 75.9 79.5 81.8 78.7 71.1 Molecular weight (KDa) 46-48 Sugar compositionc GalA (A) data obtained from Samuelsen et al. 1996 as weight% of applied material c mol% of total carbohydrate content a bcalculated 0 .3 0 .2 0 .1 0 .0 5 10 15 20 25 9 0 º d e te c to r R I d e te c to r 0 .1 4 Detector response (volts) Detector response (volts) 0 .1 6 9 0 º d e te c to r R I d e te c to r 0 .4 0 .1 2 0 .1 0 0 .0 8 0 .0 6 0 .0 4 0 .0 2 0 .0 0 30 5 10 E lu tio n v o lu m e (m l) 20 25 30 9 0 º d e te c to r R I d e te c to r 1 .4 1 .2 1 .0 0 .8 0 .6 0 .4 0 .2 0 .0 5 10 15 20 25 30 0 .0 9 E lu tio n v o lu m e (m l) 1002a 1002b 1002c 1002d 1002e 1002f 0 .0 8 Detector response (volts) Detector response (volts) 1 .6 15 E lu tio n v o lu m e (m l) 0 .0 7 0 .0 6 0 .0 5 0 .0 4 0 .0 3 0 .0 2 0 .0 1 0 .0 0 -0 .0 1 10 12 14 16 18 20 22 E lu tio n v o lu m e (m l) 24 26 Inhibition of lysis (%) 100 Effects on the complement system 80 60 40 20 P M II A 1001 A 1002 0 0 50 100 150 200 250 C oncentration ( g/m l) P M II A 1002c % Inhibition of lysis 100 A 1002 A 1002d A 1002a A 1002e A 1002b A 1002f 80 60 40 20 0 0 5 10 15 20 25 C oncentration ( g/m l) 30 35 Conclusion High mol.weight fraction of 1002 highest activity May be one or two types of molecules, If so: One basically pectic like One rich in 3-O-methylgalactose Or one with all components The effect of the polysaccharides may explain the traditional use in inflammation Plantago major Traditional use in Scandinavia: Wound healing PM II De-esterification and de-acetylation Pectinase Oxalic acid hydrolysis TFA-hydrolysis Pectolyase Periodate oxidation Structure/activity relations De-esterification and de-acetylation Hairy regions more active than smooth areas HMW hairy regions with 1,3,6 linked galactose highly active Removal of arabinose on galactose no change of activity increase activity Removal of arabinose on galacturonic acid reduce activity PM II activate the complement system Classical pathway activator Alterantive pathway activator not through C1Q (as IgG) not through the lectin pathway probably through C3 Variation in activity between different sera, 220 fold No difference in the level of antibodies against PMII in the sera Variation in individual effect PMII protects against systemic Streptococcus pneumoniae Infection in Mice PMII protects against the infection when administered systematically prechallenge Protective effect is due to stimulation of the innate immune system, not the adaptive. Conclusions Polysaccharides from different medicinal plants from various countries that traditionally are used as woundhealing agents or against inflammation have bioactivities that influence the immmunsystem in different ways in vitro, most probably also in vivo. Possible agents or leads for safe medicines as no toxic effects yet shown for polysaccharides of these types. Co-workers Cecilie Sogn Kari Inngjerdingen Drissa Diallo Haruki Yamada Hiroaki Kiyohara Terje Michaelsen Sanya Hokputsa Stephen Harding Anne Berit Samuelsen Hilde Barsett Financial support: NUFU,PRO 22/2002 Medicinal plants from Mali COST D28 Therapeutic polysaccharides